Unknown

Dataset Information

0

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.


ABSTRACT: Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, classification, and assessment of neurological endpoints applicable to clinical trials of a broad range of cardiovascular interventions. Systematic application of the proposed definitions and assessments will improve our ability to evaluate the risks of cardiovascular procedures and the safety and effectiveness of preventive therapies.

SUBMITTER: Lansky AJ 

PROVIDER: S-EPMC6251670 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.

Lansky Alexandra J AJ   Messé Steven R SR   Brickman Adam M AM   Dwyer Michael M   Bart van der Worp H H   Lazar Ronald M RM   Pietras Cody G CG   Abrams Kevin J KJ   McFadden Eugene E   Petersen Nils H NH   Browndyke Jeffrey J   Prendergast Bernard B   Ng Vivian G VG   Cutlip Donald E DE   Kapadia Samir S   Krucoff Mitchell W MW   Linke Axel A   Scala Moy Claudia C   Schofer Joachim J   van Es Gerrit-Anne GA   Virmani Renu R   Popma Jeffrey J   Parides Michael K MK   Kodali Susheel S   Bilello Michel M   Zivadinov Robert R   Akar Joseph J   Furie Karen L KL   Gress Daryl D   Voros Szilard S   Moses Jeffrey J   Greer David D   Forrest John K JK   Holmes David D   Kappetein Arie P AP   Mack Michael M   Baumbach Andreas A  

European heart journal 20180501 19


Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an eva  ...[more]

Similar Datasets

| S-EPMC7963139 | biostudies-literature
| S-EPMC3142342 | biostudies-other
| S-EPMC5524035 | biostudies-other
| S-EPMC5100172 | biostudies-literature
| S-EPMC5940527 | biostudies-literature
| S-EPMC5915804 | biostudies-literature
| S-EPMC10261889 | biostudies-literature
| S-EPMC6303427 | biostudies-literature
| S-EPMC8439670 | biostudies-literature
| S-EPMC4361459 | biostudies-literature